Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer

doi:10.5306/wjco.v13.i7.630

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3942)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

178

WORD

HTML

2076

Figures (1-3)

107

Tables (1-2)

167

Sum=2573

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

318

Download

1051

Sum=1369

Jul 24, 2022 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Oncol. Jul 24, 2022; 13(7): 630-640
Published online Jul 24, 2022. doi: 10.5306/wjco.v13.i7.630

Full Size Figure Download Figure

Figure 1 Causes of elevated carbohydrate antigen 19-9. CA 19-9: carbohydrate antigen 19-9.

Citation: Balaban DV, Marin FS, Manucu G, Zoican A, Ciochina M, Mina V, Patoni C, Vladut C, Bucurica S, Costache RS, Ionita-Radu F, Jinga M. Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer. World J Clin Oncol 2022; 13(7): 630-640
URL: https://www.wjgnet.com/2218-4333/full/v13/i7/630.htm
DOI: https://dx.doi.org/10.5306/wjco.v13.i7.630